Aehr Test Systems — FY2023 Form 10-K
Reporting period: Fiscal year ended May 31, 2023, compared primarily with fiscal 2022. This is an annual filing, not a standalone calendar 2023 Q4 report; the filing does not provide a clear standalone Q4 financial summary.
Business context
Aehr designs and sells semiconductor test and burn-in equipment, led by its FOX wafer-level systems and related WaferPak and DiePak products. Demand was driven primarily by wafer-level testing, including applications in silicon carbide power semiconductors. The company reports one business segment.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net sales | $65.0 million | $50.8 million |
| Gross profit / margin | $32.7 million / 50.4% | $23.7 million / 46.6% |
| Operating income / margin | $13.4 million / 20.6% | $7.8 million / 15.3% |
| Net income | $14.6 million | $9.5 million |
| Diluted EPS | $0.50 | $0.34 |
| Cash from operations | $10.0 million | $1.5 million |
- Revenue grew 27.8%; wafer-level products generated $63.5 million, about 98% of sales. Packaged-part products generated $1.4 million.
- Gross margin expanded 3.8 percentage points, which management attributed to lower inventory-reserve costs, manufacturing efficiencies and lower direct material costs.
- Cash, cash equivalents and restricted cash were $30.2 million at year-end, with $17.9 million of short-term U.S. Treasury investments. Working capital was $72.7 million, up from $49.0 million.
- Operating cash flow rose to $10.0 million, while inventory increased $9.5 million and receivables increased $3.8 million. Investing activities used $18.7 million, primarily reflecting Treasury purchases net of maturities and $1.4 million of property and equipment purchases.
- No borrowings were outstanding under the credit facility at May 31, 2023; $8.0 million was available. The facility maturity was extended to January 13, 2024, with a conditional extension to 2025. Operating lease liabilities were $6.3 million.
Material changes and notable items
- Wafer-level sales increased approximately $14.6 million year over year, primarily due to strong demand for FOX-P systems. Backlog increased to $24.5 million from $11.1 million, but may be rescheduled or canceled and is not necessarily predictive of future sales.
- Operating expenses rose: SG&A to $12.2 million and R&D to $7.1 million. R&D spending increased from $5.8 million as the company funded product development.
- The company issued common stock through an ATM offering for $7.3 million gross proceeds in February 2023; net proceeds were $6.8 million. This contributed to dilution.
- The company held a full valuation allowance against deferred tax assets at year-end, but said it anticipated adjusting the allowance in FY2024, subject to evidence and conditions. FY2023 income tax expense was $60,000.
- The principal Fremont facility lease was extended through fiscal 2031; the modification increased right-of-use assets and lease liabilities by $5.9 million each.
Outlook, risks and contingencies
- Management expected existing cash, operating income, receivable collections, backlog shipments, inventory sales, customer deposits and available credit to meet working-capital and capital-equipment needs over the next 12 months. No specific revenue or earnings guidance was provided.
- Customer concentration is substantial: two customers represented approximately 79% and 10% of FY2023 sales; the five largest together accounted for approximately 97%. Two customers represented 82% and 17% of year-end receivables.
- Supplier and component constraints, dependence on single- or limited-source suppliers, order cancellations or delays, and inventory obsolescence could affect shipments and margins. Inventory was $23.9 million; the auditor identified inventory valuation as a critical audit matter.
- Other disclosed risks include intense competition, qualification and reliability challenges for new products, semiconductor-industry cyclicality, foreign-market and geopolitical exposure, currency fluctuations, cybersecurity incidents and dependence on key personnel.
- The company had $26.3 million of purchase obligations due within 12 months, in addition to lease commitments. It reported no pending legal proceedings and no material off-balance-sheet financing arrangements.
- The auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective as of May 31, 2023; the auditor did not audit internal control effectiveness.
Most important facts for investors to verify
- Whether the two largest customers sustain orders and payments, and how customer concentration changes.
- Whether the $24.5 million backlog converts to shipments and revenue, given cancellation and rescheduling risks.
- Whether inventory growth is supported by demand and whether any additional obsolescence provisions are needed.
- Whether gross-margin improvement and positive operating cash flow persist as growth, supply costs and working-capital needs change.
- Progress on the conditional credit-facility extension, the FY2024 tax valuation-allowance assessment, and potential future equity financing or dilution.